These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Efficacy of a negative conversion trial and subsequent living donor kidney transplant outcome in recipients with a positive lymphocyte crossmatch. Huh KH; Kim SI; Joo DJ; Ju MK; Chang HK; Kim HJ; Kim YS; Kim MS Nephron Clin Pract; 2009; 111(1):c49-54. PubMed ID: 19052470 [TBL] [Abstract][Full Text] [Related]
7. Panel-reactive antibody levels and renal transplantation rates in sensitized patients after desensitization and human leucocyte antigen amino acid residue matching. Shang W; Dong L; Feng G; Wang Y; Pang X; Li J; Liu L; Zhang W J Int Med Res; 2013 Aug; 41(4):1333-41. PubMed ID: 23780877 [TBL] [Abstract][Full Text] [Related]
8. Cardiac transplantation in pediatric patients: fifteen-year experience of a single center. Groetzner J; Reichart B; Roemer U; Reichel S; Kozlik-Feldmann R; Tiete A; Sachweh J; Netz H; Daebritz S Ann Thorac Surg; 2005 Jan; 79(1):53-60; discussion 61. PubMed ID: 15620914 [TBL] [Abstract][Full Text] [Related]
12. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy. Holt DB; Lublin DM; Phelan DL; Boslaugh SE; Gandhi SK; Huddleston CB; Saffitz JE; Canter CE J Heart Lung Transplant; 2007 Sep; 26(9):876-82. PubMed ID: 17845925 [TBL] [Abstract][Full Text] [Related]
13. Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression. Schwartz JJ; Ishitani MB; Weckwerth J; Morgenstern B; Milliner D; Stegall MD Transplantation; 2007 Sep; 84(6):715-21. PubMed ID: 17893604 [TBL] [Abstract][Full Text] [Related]
14. Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation. Pisani BA; Mullen GM; Malinowska K; Lawless CE; Mendez J; Silver MA; Radvany R; Robinson JA J Heart Lung Transplant; 1999 Jul; 18(7):701-6. PubMed ID: 10452347 [TBL] [Abstract][Full Text] [Related]
15. Anti-T-cell-antibody prophylaxis in children: success with a novel combination strategy of mycophenolate mofetil and antithymocyte serum. Boucek MM; Pietra B; Sondheimer H; Luna M; Shaffer E; Hall P; Campbell D Transplant Proc; 1997 Dec; 29(8A):16S-20S. PubMed ID: 9414669 [No Abstract] [Full Text] [Related]
16. Effect of mycophenolate mofetil in heart transplantation. Mathieu P; Carrier M; White M; Pellerin M; Perrault L; Pelletier G; Robitaille D; Pelletier LC Can J Surg; 2000 Jun; 43(3):202-6. PubMed ID: 10851414 [TBL] [Abstract][Full Text] [Related]
17. Transplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab. Lick SD; Beckles DL; Piovesana G; Vaidya S; Indrikovs A; Barbagelata NA; Valentine V Ann Thorac Surg; 2011 Oct; 92(4):1428-34. PubMed ID: 21855854 [TBL] [Abstract][Full Text] [Related]